Overview
Mohammad Zahid is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Zahid is rated as an Experienced provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Acute Promyelocytic Leukemia, Leukemia, Bone Marrow Transplant, and Splenectomy.
His clinical research consists of co-authoring 45 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Essential Thrombocythemia.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- MANAGED MEDICAID PLAN
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
5151 Maple Ave, Dallas, TX 75235
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Texas Oncology PA
Ofobuike Okani is a Hematologist Oncology specialist and an Oncologist in Dallas, Texas. Dr. Okani is rated as an Advanced provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Essential Thrombocythemia, Paget Disease of the Breast, Breast Cancer, Pleuropulmonary Blastoma, and Bone Marrow Aspiration. Dr. Okani is currently accepting new patients.
University Of Texas Southwestern Medical Center At Dallas
Ibrahim Ibrahim is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Ibrahim is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. His top areas of expertise are Essential Thrombocythemia, Shwartzman Phenomenon, Venous Thromboembolism (VTE), Hereditary Hemorrhagic Telangiectasia, and Bone Marrow Aspiration.
University Of Texas Southwestern Medical Center At Dallas
Siayareh Rambally is a Hematologist Oncology specialist and a Hematologist in Dallas, Texas. Dr. Rambally is rated as a Distinguished provider by MediFind in the treatment of Essential Thrombocythemia. Her top areas of expertise are Sickle Cell Disease, Hemophilia A, Hemophilic Arthropathy, Thrombocytopenia, and Bone Marrow Aspiration.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Promyelocytic LeukemiaDr. Zahid isAdvanced. Learn about Acute Promyelocytic Leukemia.
- LeukemiaDr. Zahid isAdvanced. Learn about Leukemia.
- Experienced
- Achilles Tendon RuptureDr. Zahid isExperienced. Learn about Achilles Tendon Rupture.
- Acute Monoblastic Leukemia (AmoL)Dr. Zahid isExperienced. Learn about Acute Monoblastic Leukemia (AmoL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Zahid isExperienced. Learn about Acute Myeloid Leukemia (AML).
- AgranulocytosisDr. Zahid isExperienced. Learn about Agranulocytosis.